Business Context and Reporting Period
This Form 6-K filing by Rezolve AI PLC (Rezolve AI Limited) covers the month of September 2024. The report details a significant capital arrangement entered into on September 6, 2024, involving an amendment to a Standby Equity Purchase Agreement and the issuance of a promissory note to secure funding.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The primary financial data relates to debt financing and liquidity:
- Total Committed Prepaid Advances: $7,500,000.
- Initial Funding Received: $5,000,000 (comprising the first two tranches of $2,500,000 each).
- Pending Funding: $2,500,000 (third tranche, contingent on the effectiveness of an F-1 Registration Statement).
- Debt Instrument: Promissory Note issued on September 9, 2024, with a principal amount of $5,000,000.
- Interest Rate: 10% per annum on the outstanding principal balance.
- Maturity Date: September 11, 2025.
Material Changes
The material change reported is the execution of the Second Amended and Restated Standby Equity Purchase Agreement with YA II PN, LTD ("YA"). This agreement supersedes the original agreement dated February 23, 2023, and the amended version from February 2, 2024. The amendment incorporates a new prepaid advance arrangement totaling $7.5 million, structured in three tranches. Consequently, the company has increased its short-term debt obligations by $5 million immediately, with a potential additional $2.5 million upon regulatory approval.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing indicates the company is pursuing a registration statement (F-1) with the SEC, the effectiveness of which is a condition precedent for the final tranche of funding. The company retains the right to redeem portions of the note early upon 10 days' written notice under certain events.
Risks and Contingencies:
- Conversion Risk: YA may elect to convert all or part of the outstanding note amount into ordinary shares of Rezolve at a defined Conversion Price, subject to limitations, which could result in dilution.
- Regulatory Contingency: The final $2.5 million tranche is contingent upon the effectiveness of the F-1 Registration Statement filed on September 6, 2024.
- Debt Service: The company must service 10% annual interest on the outstanding principal.
Investor Verification Checklist
- Verify the status and expected effectiveness date of the F-1 Registration Statement filed on September 6, 2024.
- Review the full text of the Promissory Note (Exhibit 99.2) to understand the specific "Conversion Price" formula and limitations.
- Confirm the specific "certain events" that trigger the company's right to early redemption of the note.
- Assess the impact of potential share conversion on existing shareholder dilution.
- Check subsequent filings for confirmation of the third tranche funding ($2.5 million).